Co-Downregulation of PTEN, KAI-1, and nm23-H1 Tumor/Metastasis Suppressor Proteins in Non-Small Cell Lung Cancer

Annals of Diagnostic Pathology

Volumn 8, Issue 1, 2004, Pages 6-16

  Goncharuk, Viktor N ^a   Del Rosario, Arthur ^a   Kren, Leos ^a   Anwar, Shahgul ^a   Sheehan, Christine E ^a   Carlson, J Andrew ^a   Ross, Jeffrey S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Co downregulation; Immunohistochemistry; KAI 1; Nm23 H1; Non small cell lung carcinoma; Prognosis; PTEN; Tumor suppressor genes

Indexed keywords

FORMALDEHYDE; GLYCOPROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; PARAFFIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KAI 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CORRELATION ANALYSIS; DISEASE SEVERITY; DOWN REGULATION; EVOLUTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 1042289697     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2003.11.002     Document Type: Article

References (63)

1. Landis SH, Murray T, Bolden S, et al: Cancer statistics. CA Cancer J Clin 1999;49:8-31
2. Toloza EM, Roth JA, Swisher SG: Molecular events in bronchogenic carcinoma and their implications for therapy. Semin Surg Oncol 2000;18:91-99
3. Ihde DC, Minna JD: Non-small cell lung cancer. Part I: Biology, diagnosis, and staging. Curr Probl Cancer 1991;15:61-104
4. James CD, Carlborn E, Dumanski JP, et al: Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988;48:5546-5551
5. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-1947
6. Liaw D, March DL, Li J, et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-67
7. Koho T, Takahashi M, Mande R, et al: Inaktivation of the PTEN/ MMAC1/ TEP1 gene in human lung cancers. Genes Chromosomes Cancer 1998;22(2):152-156
8. Furnari FB, Lin H, Huang HJS, et al: Growth suppression of glioma cells by PTEN requires a functional phosphatase activity. Proc Natl Acad Sci U S A 1997;94:12479-12484
9. Li DM, Sun H: PTEN/ MMAC1/ TEP1 suppress the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A 1998;95:15406-15411
10. Petersen S, Wolf G, Bockmuhl U, et al: Allelic loss on chromosome 10q in human lung cancer. Association with tumor progression and metastatic phenotype. Br J Cancer 1998;77:270-276
11. Petersen S, Rudolf J, Bockmuhl U, et al: Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of lung. Oncogene 1998;17(4):449-454
12. Forgacs E, Biesterveld EJ, Sekido, Y, et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene 1998;17:1557-1565
13. Hosoya Y, Gemma A, Seike M, et al: Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis. Lung Cancer 1999;25:87-93
14. Sulis ML, Parsons R: PTEN: From pathology to biology. Trends Cell Biol 2003;13:4
15. Parsons R, Simpson L: PTEN and cancer. Methods Mol Biol 2003;222:147-166
16. Wright MD, Tomlinson MG: The ins and outs of the transmembrane 4 superfamily. Immunol Today 1994;15:588-594
17. Dong JT, Lamb PW, Rinker-Schaeffer CW, et al: KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886
18. Guo X, Friess H, Graber HU, et al: KAI-1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 1996;56:4876-4880
19. Guo XZ, Friess H, Di Mola FF, Heinicke JM, et al: KAI-1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology 1998;28:1481-1488
20. Radford KJ, Mallesch J, Hersey P: Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME 491). Int J Cancer 1995;62:631-635
21. Welch DR, Yang X, Phillips K, et al. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997;119:149-155
22. Yu Y, Yang J, Markovic B, et al: Loss of KAI-1 messenger RNA expression in both high-grade and invasive human bladder cancers. Clin Cancer Res 1997;3:1045-1049
23. Adachi M, Taki T, Ieki Y, et al: Correlation of KAI-1/ CD 82 gene expression with good prognosis in patients with nonsmall cell lung cancer. Cancer Res 1996;56:1751-1755
24. Higashima M, Kodama K, Yokouchi H, et al: KAI-1/ CD 82 expression in nonsmall cell lung carcinoma is a novel, favorable prostatic factor: An immunohistochemical analysis. Cancer 1998;83(3):466-474
25. Adachi M, Taki T, Koushi T, et al: Novel staging protocol for non-small cell lung cancers according to MRP-1/ CD9 and KAI-1/ CD82 gene expression. J Clin Oncol 1998;16:1397-1406
26. Tagawa K, Arihiro K, Takeshima Y, et al: Down-regulation of KAI-1 messenger RNA expression is not associated with less of heterozygosity of the KAI-1 gene region in lung adenocarcinoma. Jpn J Cancer Res 1999;90:970-976
27. DeLaRosa A, Williams RL, Steeg PS: NM23/ nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. BioEssays 1995;17:53-62
28. Leone A, Flatow U, King CR, et al: Reduced tumor incidence metastatic potential and cytokine responsiveness of nm23- transfected melanoma cells. Cell 1991;65:25-35
29. Kantor JD, McCormick B, Steeg PS, et al: Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 1993;53:1971-1973
30. Zinuk DL, McGonnigal BG, Dearolf CR: Drosophila awdkpn, a homologue of the metastasis suppressor gene nm23, suppresses the Tum-1 haematopoietic oncogene. Nat Genet 1993;4:195-201
31. Hsu S, Huang F, Wang Z, et al: The role of nm23 in transforming growth factor beta 1- mediated adherence and growth arrest. Cell Growth Diff 1994;5:909-917
32. Parhar RS, Shi Y, Zou M, et al: Effects of cytokine- mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells. Int J Cancer 1995;60:204-210
33. Baba H, Urano T, Okada K, et al: Two isotopes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line. Cancer Res 1995;55:1977-1981
34. Fukuda M, Ishii A, Yasutomo Y, et al: Decreased expression of nucleoside diphosphate kinase alpha isoform, an nm23-H2 gene homolog, is associated with metastatic potential of RAT mammory-adenocarcinoma cells. Int J Cancer 1996;65:531-537
35. Leone A, Flatow U, VanHoutte K, et al: Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: Effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 1993;8:2325-2333
36. Howlett AR, Peterson OW, Steeg PS, et al: A novel function for the nm23-H1 gene: Overexpression in human breast carcinoma cell leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 1994;86:1834-1844
37. Keim D, Hailat N, Meihem R, et al: Proliferation-related expression of p19/nm23 nucleoside diphosphate kinase. J Clin Invest 1992;89:919-924
38. Lakso M, Steeg PS, Westphal H: Enebryonic expression of nm23 during mouse organogenesis. Cell Growth Diff 1992;3:873-879
39. Kawakubo Y, Sato Y, Koh T, et al: Expression of nm23 protein in pulmonary adenocarcinomas; Inverse correlation to tumor progression. Lung Cancer 1997;17:103-113
40. Tomita M, Ayabe T, Matsuzaki Y, et al: Immunohistochemical analysis of nm23H-1 gene product in node-positive lung cancer and lymph nodes. Lung Cancer 1999;24:11-16
41. Mirejovsky T, Nhung NV, Mirejovsky P, et al: Expression of the nm23 gene in pulmonary carcinomas. Cesk Patol 1998;34:136-138
42. Volm M, Mattern J, Koomagi R: Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas. Clin Exp Met 1998;16(7):595-602
43. Bosnar MH, Pavelic K, Krizanac S, et al: Squamous cell lung carcinomas: The role of nm23-H1 gene. Mol Med 1997;75(8):609-613
44. Lai WW, Wu MH, Yan JJ, et al: Immmunohistochemical analysis of nm23-H1 in stage 1 non-small cell lung cancer: A useful marker in prediction of metastasis. Ann Thorac Surg 1996;62(5):1500-1504
45. Huwer H, Engel M, Welter C, et al: Squamous cell carcinoma of the lung: Does the nm23 gene expression correlate to the tumor stage. Thorac Cardiovasc Surg 1994;42:298-301
46. Tomita M, Ayabe T, Matsuzaki Y, et al: Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes. Lung Cancer 1999;24:11-16
47. Cox DR: Regression models in life tables. J R Stat Soc 1972;32:187-198
48. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 1957;53:457-481
49. Besson A, Robbins S, Youg W: PTEN/ MMAC1/ TEP1 in signal transduction and tumorigenesis. Eur J Biochem 1999;263:605-611
50. Hahn M, Weiland I, Koufaki O, et al: Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastasis. Clin Cancer Res 1999;5:2431-2437
51. White A, Lamb PW, Barrett JC: Frequent downregulation of the KAI-1 (CD82) metastasis suppressor protein in human cancer cell lines. Oncogene. 1998;16:3143-3149
52. Freije J, Blay P, MacDonald N, et al. Site-directed mutation of Nm23-H1. J Biol Chem 1997;272:5525-5532
53. Liu L, Zhou Q, Shi Y, et al: Slot blot analysis of metastasis suppression gene nm23 expression in human lung cancer. Hua His 1 Ko Ta Hsueh Hsueh Pao 1998;29(4):3464-3467
54. Mashimo T, Watabe M, Hirota S: The expression of the KAI-1 gene, a tumor metastasis suppressor, is directly activated by p 53. Proc Natl Acad Sci U S A 1998;95:11307-11311
55. Ko LJ, Prives C: p 53: Puzzle and paradigm. Genes Dev 1996;10(9):1054-1072
56. Davies MA, Lu Y, Sano T, et al. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and indices anoikis. Cancer Res 1998;58:5285-5290
57. Macleod K: Tumor suppressor genes. Curr Opin Genet Dev 2000;10:81-93
58. Greenblatt MS, Bennett WP, Hollstein M, et al: Mutations in p 53 tumor-suppressor gene: Clue to cancer etiology and molecular pathogenetics. Cancer Res 1994;54:4855-4878
59. Yokomizo A, Tindall DJ, Drobkin H, et al: PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 1998;17(4):475-479
60. Bains MS: Surgical treatment of lung cancer. Chest 1991;100:826-831
61. Martini N, Burt ME, Bains MS, et al: Survival after resection of stage 11 non-small lung cancer. Ann Thorac Surg 1992;54:460-466
62. Niiranen A, Niitamo-Korhonen S, Kouri M, et al: Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. J Clin Oncol 1992;10:1927-1932
63. Wada H, Hitomi S, Teramatsu T, et al: Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. J Clin Oncol 1996;14:1048-1054